Pernille Warre

Ph.D. Project

The objective of this Ph.D. project is to explore whether differences in genetic profiles of patients with psychiatric diseases and diabetes (type 1) might have an influence on the outcome and safety of their medicine use. Through critical literature reviews, analysis of associations between reported ADRs and genotypes in epidemiological studies and text mining of electronic patient records, we aim to understand how genetic factors influence on drug efficacy and toxicity and the challenges that lie ahead in translating the research into clinical practice. Data derives from the Sct. Hans Hospital and the Steno Diabetes Center.

The project involves collaboration with the Novo Nordisk Foundation, Center for Protein Research, University of Copenhagen.

Supervisors:

Associate Professor Lise Aagaard
Professor Ebba Holme Hansen
Professor Lars Juhl Jensen
Professor Søren Brunak

Education:

• Medical Sales Representatives Degree, The Danish Assosiation of the Pharmaceutical Industry, Copenhagen, Denmark, 2007
• Master of Health Science, University of Aarhus, Denmark, 2006
• Bachelor of Nursing, Nursing School of Aarhus, Denmark, 2003

Work experience:

• Pharmacovigilance Coordinator, Ferring Pharmaceuticals, Copenhagen, Denmark (March 2009-December 2010)
• Medical Information and Pharmacovigilance Officer, Chiltern International, Slough, United Kingdom (March - December 2008)
• Medical Coordinator, Prescan, London, United Kingdom (Aug 2006 - March 2008)

Contact:

University of Copenhagen
Faculty of Pharmaceutical Sciences
Department of Pharmacology and Pharmacotherapy
Universitetsparken 2
DK-2100 Copenhagen
Denmark
Phone: +45 353 36 438
E-mail:pwa(at)farma.ku.dk
www.farma.ku.dk/samfundsfarmaci
www.fama.ku.dk/socialpharmacy